• Call us
  • General

    Founded in 2016, Locsense develops non-invasive sensors like the Artemis to monitor cell health, offering a cruelty-free alternative to animal testing. Its technology measures cell barrier strength, crucial for drug testing, disease research, and understanding body defenses. Locsense devices integrate seamlessly with existing workflows and advanced in-vitro platforms like organ-on-chip and microfluidic chips.

    Artemis MT

    Artemis ST Single Transwell 12 wells

    Artemis ST Single Transwell 24 wells

    Software

    Frequently Asked Questions

    Find the answers to questions that are regularly asked by visitors to our website.

    Yes, the transwell plates can be placed inside the Artemis plate holder. The device can automatically read-out the entire plate by performing TEER and impedance spectroscopy measurements on all wells.

    Yes, in addition to the standard configuration, Locsense can provide interfacing to microfluidic chips, or organs-on-chip.

    Yes, the Artemis can perform time-lapse measurements, e.g. for a period of 24 hours or 72 hours with time intervals varying from several minutes to hours or days.

    Yes the Artemis is compatible with the incubator. The cells can be placed inside the incubator, while the Artemis detector is placed on top of the incubator.

    News

    Stay up to date with our latest developments

    Resources

    News
    Switch content
    Resources

    Join us at the European Brain Barriers meeting

    We’re excited to announce that Locsense will be joining the Brain Barriers Meeting in Bern from 8-10 September 2025! Our team will be there to connect with leading researchers and innovators in the field of brain barriers, and we look forward to sharing insights on our cutting-edge Artemis platform and the role of impedance spectroscopy…

    Read more

    Podcast Episode 34 Impedance and Impact

    In this first episode of a three-part podcast series, Susan Roelofs and Eline Geervliet from Locsense join host David Yarmosh of ATCC to share the story behind the founding of Locsense in 2016 and the company’s growth journey over the years. The discussion highlights the unique features of the Artemis platform and explores the importance…

    Read more

    Meet us at the ESDR conference in Antwerp

    Locsense will be exhibiting at the ESDR (European Society for Dermatological Research) conference in Antwerp from the 10th untill the13th of September 2025. We'll be featuring our Artemis ST, and discussing its applications in dermatological studies. This is a great opportunity to see a live demo and learn how our technology can provide deeper insights…

    Read more

    Installation Artemis at StratiCELL

    We are pleased to announce the installation of the Artemis TEER Detector at the renowned CRO StratiCell laboratory! StratiCELL and Locsense are currently collaborating to the implementation of this innovative TEER detector to monitor skin cell constructs and evaluate the effects of various compounds. This is a big step in our recent partnership, also including…

    Read more

    We will exhibit at In-Cosmetics in Amsterdam

    Experience the forefront of cosmetic technology at In-cosmetics in Amsterdam from April 8-10, 2025! Visit our booth #12C24 to explore Locsense's state-of-the-art technology designed to test cosmetic ingredients, product safety and stability. In addition, there is plenty of opportunity to explore the latest innovations in skin protection technologies and products. Mark your calendars and join…

    Read more

    Meet us at SOT in Orlando

    Locsense will be showcasing its innovative solutions at the Society of Toxicology (SOT) annual conference in Orlando. Join us to explore our latest advancements in toxicology research, connect with industry experts, and discover how Locsense is shaping the future of safety and risk assessment. Mark your calendars and visit us at Booth 532 from March…

    Read more

    Installation at Luxembourg Institute of Science and Technology

    We are delighted to announce that Luxembourg Institute of Science and Technology (LIST) is the newest user of our technology for barrier integrity monitoring. This partnership marks a significant step in advancing skin and lung research at LIST. We will keep you up posted on the results that will come out of this collaboration.

    Read more

    European Respiratory Society Congress

    Locsense will be attending The European Respiratory Society Congress (ERS), which will be held in Vienna, on September 7 - 11, 2024. For more information, click here. Stop by the Locsense booth to meet our experts and watch live demos. We look forward to seeing you in Vienna.

    Read more

    Decoding Skin Resilience

    Researchers from the Radboudumc and Locsense developed an approach to measure how genetic variants, inflammatory mediators, and drug candidates affect skin barrier development and function. The article is now in press in the Journal of Investigative Dermatology. The quantitative and longitudinal analysis of epidermal differentiation and skin barrier function in skin organotypic models was monitored.…

    Read more
    View all

    Impedance spectroscopy; what and why?

    Impedance spectroscopy is a powerful analytical technique widely used in in vitro testing to evaluate the barrier function of cell cultures. One of the most critical applications of impedance spectroscopy is in assessing the integrity of epithelial and endothelial cell layers through measurements such as trans epithelial/transendothelial electrical resistance (TEER). Transepithelial electrical resistance (TEER) and…

    Read more

    Project in the spotlight: EpiSense

    Besides providing hardware and software for impedance spectroscopy, we are actively involved in several innovative projects. One of the projects is EpiSense, where a consortium (StratiCell, Locsense and Radboudumc) develops an EPIthelial SENSing, or EpiSense, solution that accurately measures the barrier function of skin constructs. This enables researchers to improve their scientific output and CRO’s…

    Read more

    The blood-brain barrier’s role in health and disease

    The blood-brain barrier (BBB), as the name states, is a highly selective and protective interface between the bloodstream and the brain. It consists of endothelial cells that line the brain’s capillaries, forming tight junctions that restrict the passage of substances from the blood into the brain. This barrier serves several key functions [1]:

    Read more

    Importance of in vitro testing for the 3R’s

    Animal testing has long been a fundamental aspect in biomedical research, toxicology studies, and drug development. However, ethical concerns and scientific limitations have driven the development of alternative methods that align with the principles of the 3R’s: replacement, reduction, and refinement. In vitro testing has emerged as one of the most promising approaches to achieving…

    Read more

    Innovative Microphysiological Model Using HepatoXcell™ Primary Human Hepatocytes and Locsense Artemis

    The development of a highly representative in vitro gut-liver model is essential for improving drug testing accuracy while minimizing the reliance on animal studies. Traditional animal models often fail to fully replicate human physiology, leading to discrepancies in drug metabolism and toxicity predictions.1 A physiologically relevant gut-liver system would provide a more accurate platform to…

    Read more

    HMOS 2’FL and 3FL prevent house dust mite induced proinflammatory cytokine release in vitro and decrease specific IgE production in a murine allergic asthma model

    Allergic asthma is characterized by sensitization to airborneallergens like house dust mite (HDM). Human milk oligosaccharides (HMOS) are linked to improved immune maturation and potentially alleviate allergy development. Here, we describe an in vitro human airway mucosal HDM sensitization model as relevant tool to reduce use of animals in studies aiming to prevent HDM allergic…

    Read more
    View all